drugset / Trial / NCT05895162
Zinc-containing Vaginal Gel and Oral Fluconazole for Vulvovaginal Candidiasis.
RandomizedParallel-groupOpen-labelTreatment
Summary
Vaginitis is one of the most common gynecological problems in women. Candida albicans is responsible for more than 85% of vaginal fungal infections and reinfection after standard treatment is quite common. The aim of this study is to compare the effects of a zinc-containing vaginal gel and oral fluconazole on the treatment and recurrence of vulvovaginal candidiasis (VVC). The investigator's hypothesis is that zinc-containing vaginal gel may decrease the rate of reinfection after standard treatment with oral 150 mg fluconazole.
Timeline
- Start
- 2023-06-10
- Primary completion
- 2024-12-31
- Completion
- 2025-01-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JUVIA | Unknown | — | Other |
| Background | Fluconazole | Small molecule | 150 mg | — |